Skip to content

RenovoRx, Inc.

RNXT· NasdaqCore metricsCIK 1574094

Surgical & medical instruments & apparatus143 peers

Last sale
Nov 12, 2026 · -5.69%
Market cap
$55.97M
48.25M shares
Filings
293
$1.07M
Q3 2026+2,511.6% FY25 yoy
-$3.65M
Q3 2026N/M FY25 yoy
-$3.24M
Q3 2026N/M FY25 yoy
-$9.21M
Q3 2026derivedN/M FY25 yoy
-$0.08
Q3 2026N/M FY25 yoy
$10.40M
Q3 2026−1.8% FY25 yoy
$55.97M
—
20.2×
6.0×
-21.84%
—

Twelve months to Sep 30, 2026 · derived

Price

$1.16+8.41%+$0.09past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.12MFY 2025
$1.12M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,123,000reported
FY 20242024-12-31$43,000reported

Surgical & medical instruments & apparatus

RenovoRx, Inc. is the 107th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

RenovoRx, Inc. · CIK 1574094 · Engraved from SEC EDGAR